Brean Murray Carret & Co. Starts Johnson & Johnson (JNJ) at Buy

Article Stock Quotes (1) Comments (0)

Brean Murray Carret & Co. initiates coverage on Johnson & Johnson (NYSE: JNJ) with a Buy. PT $77.

Brean analyst said, "After several years of subpar fundamentals and some unexpected headwinds, J&J appears poised for earnings reacceleration, due to a pipeline-driven revenue upswing in Pharma, stable , MD&D trends and trough for Consumer sales.

For more ratings news on Johnson & Johnson click here and for the rating history of Johnson & Johnson click here.

Shares of Johnson & Johnson closed at $67.10 yesterday, with a 52 week range of $56.86-$67.37.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Michael Kors (KORS) Under-Appreciated; Canaccord Genuity Starts at Buy
• BGC Partners Starts LinkedIn (LNKD) at Buy
• Wells Fargo Starts Taylor Morrison Home (TMHC) at Outperform

Create E-mail Alert Related Categories

New Coverage

Related Entities

Brean Murray Carret & Co., Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?